accessible elisa kits hk402  (Hycult Biotech)

Journal: PLoS ONE

Article Title: H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

doi: 10.1371/journal.pone.0175572

Figure Lengend Snippet: ROC curves, ≤ 6 h post-trauma, for S100B and H-FABP, representing best performance when set to: a) 100% sensitivity; b) 90%–100% sensitivity; and c) the S100B cut-off 0.1 μ g/L.

Article Snippet: For patients recruited in Geneva, H-FABP was measured using a HK402 kit from Hycult (Hycult Biotech, Uden, The Netherlands) with a limit of quantification (LOQ) ranging between 102–25000 pg/mL, and for patients recruited in Spain it was measured using a K151HTD kit from Meso Scale (Meso Scale Diagnostics, Rockville, MD, USA) LOQ 137–100000 pg/mL.

Techniques:

Journal: PLoS ONE

Article Title: H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

doi: 10.1371/journal.pone.0175572

Figure Lengend Snippet: Performances when sensitivity was set at 100%, in the 90%–100% range, and when S100B’s cut-off was set at 0.1 μg/L, with corresponding NPV and PPV for patients ≤ 6 h post-trauma.

Article Snippet: For patients recruited in Geneva, H-FABP was measured using a HK402 kit from Hycult (Hycult Biotech, Uden, The Netherlands) with a limit of quantification (LOQ) ranging between 102–25000 pg/mL, and for patients recruited in Spain it was measured using a K151HTD kit from Meso Scale (Meso Scale Diagnostics, Rockville, MD, USA) LOQ 137–100000 pg/mL.

Techniques:

Journal: PLoS ONE

Article Title: H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

doi: 10.1371/journal.pone.0175572

Figure Lengend Snippet: The performances of H-FABP and S100B biomarkers at 100% sensitivity, ≤ 6 h post-trauma, dichotomised into younger and older patients.

Article Snippet: For patients recruited in Geneva, H-FABP was measured using a HK402 kit from Hycult (Hycult Biotech, Uden, The Netherlands) with a limit of quantification (LOQ) ranging between 102–25000 pg/mL, and for patients recruited in Spain it was measured using a K151HTD kit from Meso Scale (Meso Scale Diagnostics, Rockville, MD, USA) LOQ 137–100000 pg/mL.

Techniques:

Journal: PLoS ONE

Article Title: H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

doi: 10.1371/journal.pone.0175572

Figure Lengend Snippet: The performances of H-FABP and S100B biomarkers at 100% sensitivity, ≤ 6 h post-trauma in mTBI subgroups; isolated brain trauma or multiple trauma patients.

Article Snippet: For patients recruited in Geneva, H-FABP was measured using a HK402 kit from Hycult (Hycult Biotech, Uden, The Netherlands) with a limit of quantification (LOQ) ranging between 102–25000 pg/mL, and for patients recruited in Spain it was measured using a K151HTD kit from Meso Scale (Meso Scale Diagnostics, Rockville, MD, USA) LOQ 137–100000 pg/mL.

Techniques: Isolation